07/02/2025 19:18
IUX Deepens Commitment to African Market at Finance Magnates Africa Summit 2025

IUX made a notable impact at the Finance Magnates Africa Summit 2025 (FMAS:25) as a primary sponsor at the summit bar. The company not only stood out as a key participant but also created a dynamic atmosphere through its #DrinksOnIUX campaign. This initiative highlights IUX's commitment to expanding its presence and advancing digital trading solutions across the African region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025070125...

AFP subsidiary FACTSTORY co-produces documentary ‘Nigeria: Seeds of Hope’

FACTSTORY, an AFP subsidiary, has co-produced the documentary ‘Nigeria: Seeds of Hope’, directed by Judith Rueff and Moïse Gomis, in partnership with ARTE G.E.I.E. and France 24.

FACTSTORY, an AFP subsidiary, has co-produced the documentary ‘Nigeria: Seeds of Hope’, directed by Judith Rueff and Moïse Gomis, in partnership with ARTE G.E.I.E. and France 24.
Anglais
07/08/2025 12:00
Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical in the formation of neutralizing antibodies – for measles, mumps and rubella. This effort aims to build the most comprehensive understanding of the formation of neutralizing antibodies to the vaccine and to identify the dominant and effective antibodies to these infe...

07/08/2025 12:00
Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, announce today that the China National Medical Products Administration (NMPA) has approved Heng Qin® (Perfluorohexyloctane Eye Drops) for the treatment of dry eye disease (DED) associated...